Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.265 USD | -11.07% | -85.55% | -88.79% |
07/05 | Capital One Downgrades GlycoMimetics to Equalweight, Price Target at $0.50 | MT |
06/05 | Sector Update: Health Care Stocks Higher in Late Afternoon Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-88.79% | 19.21M | |
+3.26% | 108B | |
+11.22% | 104B | |
+1.28% | 22.33B | |
-11.89% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-9.91% | 17.64B | |
+4.44% | 14.05B | |
+34.96% | 12.51B |
- Stock Market
- Equities
- GLYC Stock
- News GlycoMimetics, Inc.
- GlycoMimetics, Thermo Fisher Unit Set Accord for Manufacturing Uproleselan for Acute Myeloid Leukemia